Sulfonamides became available for clinical use in 1936-37. At that time, they were highly effective both in vivo and in vitro against most strains of Neisseria gonorrhoeae and N. meningitidis. Subsequently, they became decreasingly effective for treatment of gonorrhea, and 75 to 85% of N. gonorrhoeae strains isolated from 1944 to 1948 were sulfonamide-resistant (31, 37) . However, N. meningitidis remained susceptible, and sulfonamides continued to be the drugs of choice for meningococcal meningitis until recently. In 1963, sulfonamide-resistant meningococcal strains were implicated in outbreaks of meningitis among military recruits (28) , and subsequently have been isolated from civilian cases (12, 26) .
As a basis for understanding the natural evolution of bacterial resistance to an antimicrobial agent, it is necessary to examine and compare strains isolated from clinical material. Yet sulfonamide resistance which arises by mutation in different strains is difficult to equate, inasmuch as the same mutation may not have the same phenotypic effect when it occurs in cells of different genetic constitution (29) . The dilemma is resolved by introducing the mutant information from various clinical isolates into a selected recipient strain which has a uniform genetic and physiological constitution. The availability of a method to accomplish this genetic transfer between various species of Neisseria (2, 3) , and of a completely defined culture medium for physiological studies (5) , prompted this genetic study of sulfonamideresistant clinical isolates of N. meningitidis and N. gonorrhoeae. The resistance of strains of both species could be introduced by transforming deoxyribonucleate (DNA) preparations into the sulfonamide-susceptible recipient, N. meningitidis strain Ne 15. Two classes of sulfonamide resistance could be distinguished by transformation. Resistance of one class was not associated with significant nutritional change, whereas that of the other was invariably associated with a requirement for methionine.
Numerous studies have been made of the antibacterial action of sulfonamides and of the development of bacterial resistance (19) . The discovery by Woods (40) that sulfonamide competitively inhibits bacterial utilization of p-aminobenzoic acid (PAB) was followed by the recognition that PAB is an essential component of folic acid. Folic acid coenzymes function as carriers of single carbon units in the biosynthesis of methionine and several other amino acids, and also of purines and thymine. Thus, the bacteriostatic action of sulfonamide is due to the ultimate shortage of the essential end products of folic acid metabolism (41) . This explains the latent period that is observed before sulfonamide measurably reduces the rate of bacterial growth (23) .
Various factors enhance the capacity of a given bacterial strain to multiply in the presence of a concentration of sulfonamide higher than the minimal inhibitory concentration established for that strain under standard conditions. These may be grouped into two categories depending on whether genetic change is or is not associated with the increased resistance: phenotypic resistance and genetic resistance.
In the absence of any genetic change (phenotypic resistance), the bacteriostatic action of sulfonamide is reduced by exogenous supplementation of the bacterial environment with PAB (40) or with one or more of the essential products of folate metabolism (41) . Thus, methionine was shown to be an antagonist of sulfonamide for Escherichia coli (15) ; moreover, the methionine biosynthetic pathway was recognized as being the most sensitive to inhibition by sulfonamides (38) .
Genetic changes resulting in increased endogenous supplies of PAB (24, 40) , or in alteration of a PAB-utilizing enzyme with consequent decreased affinity for sulfonamides (7, 17) , were proposed to account for increased resistance. Recent work with two cell-free systems has shown that enzymes which catalyze the formation of folate compounds from PAB indeed do differ structurally: those extracted from sulfonamideresistant mutants combine with sulfonamide less readily than do the corresponding enzymes extracted from the original parent bacteria (30, 39) . Furthermore, a genetic parallel to the end-product antagonism of sulfonamide bacteriostasis is found in certain mutational events that impose a nutritional requirement for methionine. It will be shown that N. meningitidis clones, which are unable to perform this folate-catalyzed biosynthetic reaction because of a genetic block introduced by spontaneous mutation or by transformation, are able to multiply in a defined medium containing methionine together with sulfadiazine at a concentration higher than that sufficient to inhibit growth of the parental strain in the same methionine-containing medium.
MATERIALS AND METHODS
Chemicals. Inorganic chemicals and PAB were certified reagent grade obtained from Fisher Scientific Co., Pittsburgh, Pa. Crystalline vitamin B12 was from Sigma Chemical Co. (St. Louis, Mo.). Calbiochem (Los Angeles, Calif.) supplied the S-adenosyl-Lmethionine (B grade) and all amino acids (A grade, "chromatographically homogeneous") except DLhomocysteine free base (Nutritional Biochemicals Corp., Cleveland, Ohio). Homocysteine also was prepared immediately before use from L-homocysteine thiolactone hydrochloride (A grade, Calbiochem) by addition of alkali by two slightly different methods (11, 16) . L-Homocystine ("chromatographically homogeneous"), found to be contaminated with methionine, was recrystallized from a solution in hot sodium acetate buffer (0.05 M, pH 6). Crystalline dihydrostreptomycin sulfate (USP; E. R. Squibb & Sons, New Brunswick, N.J.) and sodium sulfadiazine (solution, 0.25 g/ml; Lederle Laboratories, Pearl River, N.Y.) were the antibacterial agents used. Crystalline pancreatic deoxyribonuclease (sterile; Worthington Biochemical Corp., Freehold, N.J.) was used to destroy activity of transforming DNA.
Media. The complex medium (HIY-1) used routinely for growth and transformation tests of N. meningitidis Ne 15 has been described (2) . It contains Difco Heart Infusion Broth, Yeast Extract, and Bacto-agar (1.4%, w/v, for hard agar and 0.7% for soft agar), together with calcium and other supplements.
N. gonorrhoeae was cultivated (35 C with 5 to 10% C02) on chocolate-agar prepared with Proteose No. 3 Agar (Difco) and 5% sheep blood.
The defined medium was prepared by methods detailed previously (5) . The components of solutions A and B (mineral salts), and D (sodium lactate), were the same as before, but other components were changed. As the sodium glutamate employed earlier was found to be contaminated with methionine (a difficulty also encountered by others (9, 27) , glutamic acid was used (final concentration, 8.0 mM). The sodium salt was prepared by slow addition of 2 N sodium hydroxide (to the 400 mm stock) to give pH 7.4. Serine was routinely added at a concentration of 0.2 mM; though not required, it promoted growth in defined fluid of some transformants (Sul-r Met+). The remaining components of the routine medium were arginine (0.5 mM), glycine (2.0 mM), calcium chloride (0.2 mM), ferric sulfate (0.01 mM), and glycerine (0.5%, v/v). As emphasized before (5), the pH of the final medium must be rigidly controlled (7.4 i 0.1) in order to obtain growth of N. meningitidis from small inocula. To avoid pH changes associated with autoclaving, the various stock solutions (except CaCl2, glycerine, and agar) were (10) , the following phenotypic abbreviations will be used. Sul-r20 Met+ will refer to mutant strains or transformants which are able to produce colonies on HIY-1 agar containing suifadiazine at a concentration of 20 ,g/ml, but not at 100 ,g/ml, and which do not show a nutritional requirement for methionine in defined medium. Sul-r Met+ indicates strains that produce fast-growing colonies on 100 Mg of sulfadiazine per ml, and do not require methionine. Sul-r/Met-will refer to strains which reproduce on sulfadiazine-containing agar more slowly and require methionine for growth in defined medium; the two characteristics are acquired concurrently during transformation. Str-r will refer to strains which are resistant to dihydrostreptomycin (DHS) incorporated in HIY-1 agar at a concentration of 500,g/mI.
DNA donor strains. Strains of N. meninigitidis and N. gonorrhoeae which were resistant to sulfadiazine when isolated from clinical material were received from other laboratories ( Table 1) . The four meningococcal strains were all serological group B, as were the streptomycin-resistant mutants derived from them. Methods used at Statens Seruminstitut to isolate and identify gonococci, and results of susceptibility studies, have been published (31, 32) . To simplify the presentation and discussion of transformation results, roman numerals will be used to designate DNA preparations from these clinical isolates.
DNA preparations I-VI were obtained from Str-r strains. The Str-r mutants of N. meningitidis were derived by the method previously described (4 For sulfadiazine resistance, only slight modification of the test method was required. Phenotypic expression of resistance to sulfadiazine did not require prolonged incubation in drug-free medium, but occurred in SULF agar during the time that the intracellular concentration of critical metabolic products was being depleted (23, 41) . A sample of the recipient cell plus DNA reaction mixture was added to HIY-l soft agar containing sulfadiazine and was overlaid in 5-ml volumes on five plates of hard agar of similar composition. Cultures were incubated (35 C, humidified air atmosphere) for 3 to 6 days before colonies were counted, growth of Sul-r/Met-transformants being much slower than Sul-r Met+ on media containing 100 pug and especially 200 pug of sulfadiazine per ml.
The lowest concentration of sulfadiazine, 20 pg/ml, used routinely in transformation tests was selected after considerable preliminary study. The method for assay of total colony-forming units, details concerning the recipient cell plus DNA reaction mixture, and various precautions have been described before (2-4).
Transformation to prototrophy of methioninerequiring strains was examined by use of defined medium. Met-recipient cells were grown for 12 to 14 hr on agar medium, usually defined agar supplemented with 0.05 mm methionine, or occasionally HIY-1 agar. Cells were removed with a loop and suspended in defined fluid, prewarmed to For determination of the total number of treated cells (expressed as colony-forming units), dilutions in defined fluid were plated in triplicate (by the overlay method) in defined agar containing 0.1 mm methionine.
Replica plating. Cells from a DNA reaction mixture, suitably diluted, were spread with a sterile glass rod over the surface ofHIY-1 agar containing 20 ,g of sulfadiazine per ml. After incubation (35 C, 20 to 40 hr), the transformant colonies on this "master" plate were sampled by pressing gently against sterile velvet stretched over a flat circular form. Cells were transferred, by similar pressure, from the velvet to the surfaces of as many as eight sterile agar media. Faithful replicas of colonies on the "master" plate were obtained by using damp velvet cloth (circles in large petri dishes were autoclaved within a few hours of use) and agar plates which had been judiciously dried (retained at room temperature long enough to eliminate subsequent development of surface moisture, which displaces the cells, but not so long as to become wrinkled, a deterrent to growth).
PAB. Two methods were used to determine the concentration of PAB or compounds having PABequivalent activity. The first employed PAB Assay Medium (Difco) with slight modification of the method described (Difoc Supplementary Literature, Difco Laboratories, Detroit, Mich.). Stock strains of Acetobacter suboxydans ATCC 621 exhibited filamentous cells and flocculent growth which tended to adhere to glass. More homogeneous growth was obtained in the assay medium by using a small inoculum of cells selected from smooth colonies. Cultures (10-ml volumes aseptically distributed in 125-ml screwcap flasks) were shaken continuously during incubation (30 C, 60 hr). Readings of optical density were made at 650 m,u (Spectronic-20 colorimeter) after diluting each culture with an equal volume of water and mixing thoroughly. Characteristics of this assay system (e.g., appreciable growth in the absence of added PAB) were such as to make quantitative aspects of the test dubious (22) .
Therefore, an independent method was devised to compare the sulfadiazine-antagonizing activities of defined culture filtrates from various strains of N.
meningitidis. For this, defined agar with Fisher glutamate (5) containing 0.6 ,ug of sulfadiazine per ml was pipetted aseptically in 20-ml volumes into flat-bottom Pyrex petri dishes. Left overnight at room temperature, the agar became dry enough to accept a 4-ml overlay of soft defined agar (with sulfadiazine, 0.6 ug/ml, and an inoculum of N. Cross-resistance. Sulfadiazine was the only sulfonamide examined in quantitative tests. However, qualitative tests were performed to determine whether resistance of the N. meningitidis strains applied to other sulfonamides as well. HIY-1 agar was used: 20-ml bottom layers and 3-ml overlays of soft agar inoculated with not more than 106 cells from a 16-to 18-hr HIY-1 agar culture. Commercially available paper discs (generously provided by BBL) containing 0.25 mg of each compound were placed on the solidified agar. Plates, after incubation for 24 hr, were examined for significant inhibition of bacterial growth (zones with a radius greater than 1 mm) peripheral to the discs. The meningococcal strain Ne 15 used as recipient in transformation tests was susceptible to the following compounds: (a) sulfadiazine, (b) sulfathia-
Strains 64-84, 64-129, and NM-131 were insusceptible to compounds a-g and susceptible to compounds h-j. Transformant clones picked from HIY-1 agar containing 200 ,ug of sulfadiazine per ml showed similar patterns of resistance, except that some remained susceptible to compound g.
RESULTS
Sulfadiazine resistance transformation frequencies. DNA preparations from a variety of sulfadiazine-resistant strains of Neisseria had transforming activity for the sulfadiazine-susceptible meningococcal strain Ne 15 (Table 2) . Genetic information which evoked resistance to 20 ug of sulfadiazine per ml or to 500 ,4g of DHS/ml (reference marker) was introduced separately but at frequencies which did not differ greatly, except for the DNA examined in test 10 . This DNA produced twice as many transformants resistant to sulfadiazine (20 ,g/ml) as to DHS, owing to the fact (established by replica plating, and discussed below) that two different kinds of transformant colonies were being counted on agar containing 20 Mg of sulfadiazine per ml.
DNA preparations from N. gonorrhoeae and N.
perflava elicited transformations at lower frequencies than those typical of N. meningitidis DNA, as expected of inter-specific transformation (3). The sulfadiazine resistance of DNA donor strains could be inferred in relative terms from the 20 Mg of sulfadiazine per ml revealed a nutritional difference. The type which produced small colonies on agar containing sulfadiazine was invariably methionine-requiring ( Fig. 1-7) . Methionine-free defined agar (Fig. 1) Fig. 8-12 are a series of replicas from a single transformation plate (20 tig/ml; n-ot showni) from test 6, Table 2 . Growth responses of cells from identical clones can be compared on defined agar lackinig methioninie (Fig. 1) or with methioninie at concentrations of 0.005 mmi (Fig. 2, 8) , 0.05 mm (Fig.  3) , 0.1 mmi (Fig. 4, 9) ; HIY-1 agar with 100 mg ofsulfadiazine per ml (Fig. 5, 10) , with 20 pAg/ml (Fi. 6, 11), or sulfadiazine-free (Fig. 7, 12 ). Photographs are noz magnzified and nol retouched. ( Fig. 2) . Progressively higher concentrations of methionine (0.05 mm, Fig. 3; 0.1 mm, Fig. 4) promoted proportionally better growth of these colonies. Their growth after 2-day incubation on HIY-1 agar with 100 ,g of sulfadiazine per ml (Fig. 5) , as expected, was less than on 20 ,g/ml (Fig. 6) or on drug-free agar (replicated last, Fig. 7) . The methionine content of HIY-1 agar was sufficient for optimal growth of the methionine-requiring transformants in the absence of sulfadiazine. Thus, when growth on HIY-1 agar was initiated from isolated cells, Sul-r Met+ colonies and Sul-r/Met-colonies were indistinguishable. Differences observed in Fig. 7 reflect the differing size of the original transformant colonies on the sulfadiazine (20 Ag/ml) "master" plate, the velvet pile design being due to the relatively dry agar which restricted growth.
The transformant colonies produced by gonococcal DNA VI (test 6, Table 2 ) were shown by replica plating to be all of the methionine-requiring type. Their response to methionine was the same as that of other Sul-r/Met-transformants, as to degree of growth on the defined agar supplemented with low concentrations of methionine (0.005 mm, compare Fig. 8 with Fig. 2) , and optimal growth at a concentration of 0.1 mM (Fig. 4, 9) . Various transformant clones differed somewhat in their capacity to tolerate sulfadiazine, as revealed by the decreased number of transformants with increased concentration. An example is provided by the colony, located close to the numeral in Fig. 12 , which produced no growth on 100 Mug of sulfadiazine per ml (Fig. 10) and only limited growth on 20 mg/ml (Fig. 11) during the 2-day incubation period.
A few Met+ papillae appeared on Met-colonies on defined agar containing low concentrations of methionine (Fig. 8 ). Very few occurred on methionine-free agar, and they were present only rarely at corresponding sites on companion replica cultures. The replica-plating technique (25) (Table 1) which also had been isolated during the sulfonamide era. Retained in the lyophilized state during the intervening years, these strains were received after the nutritional difference between Sul-r transformants was recognized. Therefore, precautions were taken to avoid laboratory manipulations which might affect the genetic constitution of these gonococci. They were cultivated on drug-free chocolate-agar exclusively; only a few subcultures were made, and these were initiated from a considerable number of typical colonies.
Transforming activities of DNA preparations from all the strains of N. gonorrhoeae were determined, and transformant colonies which developed on sulfadiazine (20 Ag/ml) -agar (300 or more for each DNA) were examined by replica plating. The frequencies of transformation obtained with DNA preparations VI-XI were not all alike (Table 3) , and different degrees of resistance were elicited. Nevertheless, the transformants obtained were uniformly methionine-requiring. A few Met+ colonies were present on transformation plates containing sulfadiazine (20 ,ug/mI) -agar, but their number was not greater than the number of Sul-r Met+ spontaneous Ne 15. Results described for this class of transformants suggested that the two phenotypic properties, sulfonamide resistance and requirement for methionine, were acquired concurrently. To obtain insight into the relationship, various Sul-r/Metstrains were examined to determine which step in the biosynthetic pathway was affected. Also, the Met-strains were used as recipients in transformation tests to see whether their biosynthetic defects could be corrected by genetic information derived from various other Met-strains. Recovery of Met+ transformants in such crosses testified to the nonidentity of the genetic alterations underlying the methionine requirement. Furthermore, the Met+ transformants so obtained were tested on sulfadiazine-agar to determine whether loss of the methionine requirement was accompanied by loss of resistance. Growth response to methionine and possible precursors. Methionine biosynthesis by various members of Enterobacteriaceae involves a series of reactions leading from homoserine and cysteine VOL. 94, 1967 to cystathionine. Cleavage of cystathionine yields homocysteine. Three genetic loci govern the structures of three enzymes which catalyze these reactions. Mutations affecting any of these loci result in a nutritional requirement for methionine, which can be replaced by homocysteine (14, 20, 36) . The final reaction of the biosynthetic sequence involves the methylation of homocysteine to yield methionine. This step in E. coli and Salmonella typhimurium is a complex one which involves methyltetrahydrofolates as the immediate sources of the transferred methyl group (6) . Auxotrophic mutants blocked in the performance of the terminal step show a methionine requirement which cannot be replaced by any of the previous compounds in the series (6, 14, 36) .
The following Sul-r/Met-transformants of Ne 15 were tested: isolates from sulfadiazine (20 Ag/ml)-agar of tests 8, 9, 10 ( Table 2) , and from tests with DNA VI (isolates g2, g52), VII (g54), VIII (g22), IX (g7), X (g55), and XI (g58). Also, Of these supplements, only methionine promoted significant growth of Sul-r/Met-colonies on defined agar. Trace activity observed for Sadenosylmethionine was attributed to methionine, arising by decomposition. Furthermore, PAB, vitamin B12, and folic acid (diffusing from separate discs saturated with 1 mg/ml solutions) did not increase the growth of Sul-r/Met-strains on defined agar with 0.005 mm methionine, a suboptimal concentration.
Some of the compounds restricted or delayed growth of the Met+ strain. After 24-hr incubation, colonies were either absent or small on the highest concentrations listed of cysteine (also cysteine plus homoserine, each at 0.25 mM), homocysteine, homocystine, and S-adenosylmethionine. No effect was found with lower concentrations. Methionine did not affect colonial growth of Ne 15 Met+ at concentrations below 0.05 mM; however, above 0.5 mm, a temporary inhibition was evident. This inhibitory effect, which was marked with 5.0 mM methionine, resembles the regulation of methionine biosynthesis in E. coli, in which methionine represses the formation of enzymes required for its own synthesis (21, 33) . Growth of Sul-r/Met-strains on defined agar was optimal with methionine at 0.1 to 0.5 mm. As with the parent strain, their growth was inhibited progressively by concentrations higher than 1.0 mm. At suboptimal concentrations, the size of colonies was a sensitive indicator of available methionine [including that amount which might be introduced as a contaminant of "pure" amino acids (9, 27)]. Colonies on defined agar with 0.0005 mm methionine were barely visible after incubation for 24 hr, and thereafter increased in size only slightly if at all. No isolated colonies were macroscopically visible in 24 hr on unsupplemented defined agar cultures of any Sul-r/Met-strain, but after longer incubation microcolonies could be detected with 4 x magnification. The strains differed from one another only slightly in regard to the size of these microcolonies, although their sulfadiazine resistances differed considerably.
In a further attempt to discern some relation between amount of methionine required and concentration of sulfadiazine tolerated, strains of differing resistance were streaked on defined agar lacking serine but containing five different concentrations of methionine alone or in combination with sulfadiazine (0.05 and 0.1 ,ug/ml, separate series). A concentration of 0.05 ,tg of sulfadiazine per ml in the defined agar, either with or without methionine, was sufficient to inhibit growth of the parent strain. (At lower concentrations of sulfadiazine, methionine exerted an antagonizing action, as expected.) All of the Sulr/Met-strains could tolerate 0.05 and 0.1 ,tg of sulfadiazine per ml. (Some were inhibited by 0.5 ,ug/ml.) Their colony size was determined, as on drug-free medium, by time of incubation and concentration of methionine. Thus, the challenge of a low dose of sulfadiazine did not affect the degree of response to methionine of the various Met-strains, though they differed in degree of resistance.
Transformation of Metr strains. To obtain basic knowledge of the particular met locus which controls the Sul-r/Met-phenotype, a preliminary study was made of spontaneous mutants of strain Ne 15. Colonies, picked from sulfadiazine-containing HIY-1 agar, were subcultured on sulfadiazine-free agar and screened for methionine requirement and genetic stability. DNA was extracted from six of these Sul-r/Met-mutants. Ml and M33 were strains which had been isolated from agar containing 20 Mg of sulfadiazine per ml, M54 and M58 were from 50 ,g/ml, and M61 and M69 were from 100 lg/ml. All Two additional DNA preparations examined in other tests (7, 8, Table 2 ) were included in all these experiments (Tables 4, 5 ). The str gene provided a reference marker outside the met locus for measuring competence of the strain. DNA from the Sul-r20 Met+ strain was used to determine the efficiency of the process of genetic elimination of the mutant site by the wild-type met locus. The frequency of transformation of Met-recipients by this preparation (one-point cross) was always higher than that found in tests of the DNA from Met-strains (two-point crosses), implying some degree of linkage between the mutant met sites of donor and recipient (13) . Close linkage of the mutant sites of M54 and M58 was indicated by the very low frequencies of reciprocal transformation. However, nonidentity of these sites was revealed by other tests with a Sul-r/Met-recipient (Ml 13) which was transformed by DNA from M54 but not from M58.
Strain Ne 15 Sul-r/Met-Str-r 64 was a multistep Sul-r mutant; that is, its high degree of sulfadiazine resistance was the result of multiple independent mutations. Its responses as recipient ("64") are given in The pattern of response obtained with recipient "64," discussed in connection with Table 4 , was similar to that of recipient 1(64), shown in Table   5 . Another recipient 2(64) also was similar. As strains 1(64) and 2(64) were derived by transformation of Ne 15 with DNA from "64" (test 8, (41) . Therapeutic failures were recorded in more than 75% of cases of gonorrhea treated with sulfonamides during 1945-1948 (31, 37) . Within a decade of the advent of penicillin therapy, however, sulfonamide-resistant gonococci were reduced to their former low incidence (31, 37) because they were as susceptible to penicillin as were other gonococci.
The four clinical isolates of N. meningitidis exhibited a different type of sulfadiazine resistance, which was not associated with increased auxotrophy. Although the Sul-r/Met-property is acquired readily by meningococci as a result of spontaneous mutation or by transformation, the degree of resistance afforded is less than that characteristic of the four Sul-r Met+ strains isolated from patients with meningitis. These are presumably representative of the highly resistant group B meningococci, which first attracted attention in 1963 (28) and subsequently have become relatively prevalent in some areas of the United States (26) .
The enzymatic basis of sulfonamide resistance in Neisseria has not been established. However, evidence available from other investigations suggests that folate compounds are ultimately involved in both types of resistance described here. Thus, work with cell-free enzymes of E. coli has revealed that sulfonamides inhibit folate biosynthesis by competing with PAB as substrate for the enzyme system that catalyzes the formation of dihydropteroic acid from PAB and 2-amino-4-hydroxy -6-hydroxymethyldihydropteridine (1). Furthermore, enzymes extracted from sulfonamide-resistant mutants combine with sulfonamides less readily than does the corresponding enzyme extracted from the parent strain (30) . Sulfonamide resistance arising by mutation in Diplococcus pneumoniae also was shown (39) to be due to structural alteration of a PAB-utilizing enzyme, and transformation methods were applied in genetic analysis of the resistant mutants (17) . Similarly, the Sul-r Met+ meningococcal strains may possess genetically altered enzymes for catalyzing this step of folate biosynthesis.
In enteric bacteria, the conversion of homocysteine to methionine is a complex reaction which involves the creation of the methyl group as methyltetrahydrofolate, and its subsequent transfer to homocysteine by either of two enzyma-J. BACTERIOL. tic mechanisms (6) . The met locus affected in N. meningitidis resembles the metF locus of S. typhimurium (36) and Proteus mirabilis (14) in that the requirement is satisfied by methionine only. S. typhimurium metF100 lacks N5N10-methylenetetrahydrofolate reductase, which catalyzes the reduction of N5N10-methylenetetrahydrofolate to N5-methyltetrahydrofolate (6) . If the Sul-r/Metstrains of Neisseria are genetically similar to metF, their defects likewise must involve alteraions of the corresponding reductase.
Whether meningococcal auxotrophs blocked at other steps of the methionine biosynthetic pathway are also sulfadiazine-resistant is not known yet. With E. coli mutants auxotrophic for homocysteine or for vitamin B12, the minimal inhibitory concentration of sulfathiazole showed a 20-fold increase in the presence of B12 or methionine (8) .
[The relation between vitamin B12 and methionine has been clarified recently; see Cauthen et al. (6) .] Possibly, any genetic event which imposes a requirement for exogenous methionine simultaneously confers some degree of sulfonamide tolerance by exerting a sparing effect on the available single-carbon units. Such a change, simultaneously affecting two properties, is not unique. Recent reports have documented the concurrent appearance of resistance to aminopterin and a specific sensitivity (34) , and of resistance to other inhibitors of dihydrofolate reductase concurrently with nutritional requirements for certain end products of biosyntheses involving tetrahydrofolate-containing coenzymes (35) .
As a selective agent for auxotropic mutants of Neisseria, sulfadiazine appears to be quite specific for spontaneous mutations which affect the particular locus corresponding to metF of Salmonella (36) . This locus of Neisseria was revealed to be complex, having a number of sites which undergo recombination. Additional evidence that the number of sites is large is provided by results of transformation tests (to be described elsewhere) with 89 Sul-r/Met-spontaneous mutants. These were used as recipients in two-point crosses with six DNA preparations (Table 4) from Sul-r/Metmutants; the transformation patterns indicated that not more than 3 of the 89 were possibly the same as any of the 6 DNA donor mutants. This met locus is of considerable interest, therefore, because it promises to be a powerful tool for study of genetic fine structure of members of Neisseria, and of genetic homology. The data presented here (Tables 4 and 5) , furthermore, reveal a correspondence of metF loci of N. meningitidis, N. gonorrhoeae, and N. perflava.
